Effect of tolvaptan on acute heart failure with hyponatremia – A randomized, double blind, controlled clinical trial

OBJECTIVES: To assess the efficacy of tolvaptan in acute heart failure with hyponatremia using a randomized double-blinded placebo-controlled study design. BACKGROUND: Tolvaptan is a selective vasopressin receptor 2 antagonist. There are no published clinical trials on the utility of tolvaptan in ac...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Indian Heart J
Autors principals: Shanmugam, Elangovan, Doss, C.R. Madhu Prabhu, George, Melvin, Jena, Amrita, Rajaram, Muthukumar, Ramaraj, Balaji, Anjaneyan, Karthik, Kanagesh, B.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4824334/
https://ncbi.nlm.nih.gov/pubmed/27056648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2015.07.006
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars